{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:09:00Z","timestamp":1780463340669,"version":"3.54.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Using plain orbital computed tomography (CT) scan images, we quantitatively extracted indicators such as diameters, cross-sectional areas, volumes, and densities of intraorbital soft tissues to investigate the feasibility of these metrics for assessing inflammatory activity status in patients with thyroid-associated ophthalmopathy (TAO).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This study retrospectively recruited 31 patients with active TAO, 46 with inactive TAO, and 46 normal controls between April 2022 and October 2025 (note: counts of inactive TAO patients and normal controls overlapped due to contralateral eye classification in TAO patients). Clinical and imaging data were collected, and eyes were stratified into three groups: 50 active TAO eyes, 79 inactive TAO eyes, and 87 normal eyes. Orbital CT scans and 3D image analysis (3D Slicer 5.7.0) were performed to measure exophthalmos, axial length, globe width, cross-sectional areas (CSA) of individual\/total extraocular muscles (EOMs), lacrimal gland CSA\/volume (LGV), optic nerve CSA, intraorbital fat thickness\/volume (IOFV), and densities of lacrimal gland, vitreous, and intraorbital fat. Ratios of LGV, IOFV, lacrimal gland CSA, and total EOMs CSA (OM) to total orbital volume (TV)\/CSA (TOA) were calculated. The Kruskal\u2013Wallis\n                      <jats:italic>H<\/jats:italic>\n                      test was used for intergroup comparisons, with pairwise Mann\u2013Whitney\n                      <jats:italic>U<\/jats:italic>\n                      tests and Bonferroni correction (\n                      <jats:italic>\u03b1<\/jats:italic>\n                      =0.017) applied for significant parameters. Point-biserial correlation was used to quantify associations with active TAO, and receiver operating characteristic (ROC) curve analysis (maximum Youden index) was used to evaluate diagnostic value.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      This study included 67 TAO patients (men:women = 35:32) with a 92.5% (62\/67) bilateral involvement rate. Kruskal\u2013Wallis\n                      <jats:italic>H<\/jats:italic>\n                      test showed significant differences among the active TAO, inactive TAO, and control groups in OM, CSA of the superior\/inferior\/medial rectus muscles, superior\/inferior oblique muscles, TOA, lacrimal gland CSA, Intraorbital fat density, IOFV, vitreous density, lacrimal gland density, and the ratios of IOFV\/TV, OM\/TOA, and lacrimal gland CSA\/TOA (all\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt;0.05). Mann\u2013Whitney\n                      <jats:italic>U<\/jats:italic>\n                      tests revealed that patients with active TAO had significantly higher superior\/medial rectus CSA, OM, Intraorbital fat density, and OM\/TOA ratio than those in the inactive TAO and control groups (all\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.017). Point-biserial correlation analysis confirmed positive correlations between these five parameters and active TAO status (\n                      <jats:italic>r<\/jats:italic>\n                      &amp;gt; 0; all\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.05). ROC curve analysis demonstrated their diagnostic efficacy for active TAO: Intraorbital fat density \u2265 \u2212 78.5 HU (area under the curve [AUC] = 0.830, sensitivity: 76.0%, specificity: 89.2%), OM\/TOA ratio \u2265 0.301 (AUC=0.829, sensitivity: 86.0%, specificity: 70.5%), superior rectus CSA \u2265 49.115 mm\n                      <jats:sup>2<\/jats:sup>\n                      (AUC=0.812, sensitivity: 64.0%, specificity: 87.3%), OM \u2265 254.12 mm\n                      <jats:sup>2<\/jats:sup>\n                      (AUC=0.825, sensitivity: 68.0%, specificity: 82.5%), and internal rectus CSA \u2265 43.525 mm\n                      <jats:sup>2<\/jats:sup>\n                      (AUC=0.749, sensitivity: 58.0%, specificity: 84.3%) (all\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The measurement of the CSA of the superior rectus muscle at 7\u00a0mm posterior to the orbital globe, the CSA of the medial rectus muscle, OM, Intraorbital fat density, and the OM\/TOA ratio via plain CT scan serves as a reliable and feasible technical approach for evaluating disease activity in patients with TAO in primary ophthalmic healthcare institutions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1767565","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:53:29Z","timestamp":1780462409000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The application value of quantitative analysis of orbital soft tissue parameters on plain CT scans in evaluating the activity of thyroid-associated ophthalmopathy"],"prefix":"10.3389","volume":"17","author":[{"given":"Gang","family":"Ji","sequence":"first","affiliation":[{"name":"Department of Radiology, Mian Yang Wanjiang Eye Hospital","place":["Mianyang, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-min","family":"Mo","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mian Yang Wanjiang Eye Hospital","place":["Mianyang, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1080\/02713683.2020.1776331","article-title":"Clinical management and therapeutic strategies for the thyroid-associated ophthalmopathy: current and future perspectives","volume":"45","author":"Mishra","year":"2020","journal-title":"Curr Eye Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1510030","article-title":"Graves' disease","volume":"375","author":"Smith","year":"2016","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4103\/meajo.MEAJO_91_17","article-title":"Epidemiology and clinical features of thyroid-associated orbitopathy in Accra","volume":"24","author":"Ackuaku-Dogbe","year":"2017","journal-title":"Middle East Afr J Ophthalmol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.53.1518","article-title":"Graves' ophthalmopathy: epidemiology and natural history","volume":"53","author":"Hiromatsu","year":"2014","journal-title":"Intern Med"},{"key":"B6","article-title":"Advances in imaging research of thyroid-associated orbitopathy","volume":"17","author":"Mo","year":"2020","journal-title":"Chin J Med Ultrasound (Electronic Edition)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1046\/j.1365-2265.2001.01349.x","article-title":"Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment","volume":"55","author":"Dickinson","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-016-3538-0","article-title":"Quantitative analysis of orbital soft tissues on computed tomography to assess the activity of thyroid-associated orbitopathy","volume":"255","author":"Byun","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3969\/j.issn.1674-361X.2024.12.002","article-title":"Policy interpretation: \"Circular on enhancing first-contact and referral services to improve healthcare continuity","volume":"16","year":"2024","journal-title":"China Rural Health"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(14)72787-4","article-title":"Diagnostic criteria for Graves' ophthalmopathy","volume":"119","author":"Bartley","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.12688\/f1000research.12787.1","article-title":"New advances in understanding thyroid-associated ophthalmopathy and the potential role for insulin-like growth factor-I receptor","volume":"7","author":"Smith","year":"2018","journal-title":"F1000Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2011.10.004","article-title":"Ethnic differences in the clinical presentation of Graves' ophthalmopathy","volume":"26","author":"Chng","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn321828-20230912-00046","article-title":"Imaging assessment of the activity and treatment efficacy of thyroid associated ophthalmopathy","volume":"44","author":"Liu","year":"2024","journal-title":"Chin J Nucl Med Mol Imaging"},{"key":"B14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3760\/cma.j.cn121383-20240126-01073","article-title":"Advances in imaging studies of thyroid-associated ophthalmopathy","volume":"45","author":"Liu","year":"2025","journal-title":"Int J Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.13609\/j.cnki.1000-0313.2021.06.007","article-title":"Quantitative measurements of lacrimal gland on conventional MRI in predictive value of glucocorticoid therapy for thyroid-associated ophthalmopathy","volume":"36","author":"Chen","year":"2021","journal-title":"Radiologic Pract"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3980\/j.issn.1672-5123.2021.6.18","article-title":"Imaging application of thyroid associated ophthalmopathy","volume":"21","author":"Yang","year":"2021","journal-title":"Int Eye Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.13929\/j.issn.1003-3289.2024.11.008","article-title":"Multiparametric quantitative MRI for diagnosis of thyroid-associated ophthalmopathy complicated with dysthyroid optic neuropathy","volume":"40","author":"Peng","year":"2024","journal-title":"Chin J Med Imaging Technol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.13281\/j.cnki.issn.1004-4469.2018.05.003","article-title":"Quantitative analysis of orbit structure on computed tomography to assess the activity of thyroid associated ophthalmopathy","volume":"27","author":"Tuo","year":"2018","journal-title":"Ophthalmol China"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1672-173X.2007.01.046","article-title":"Diagnostic value of computed tomography in thyroid-associated ophthalmopathy","volume":"38","author":"L\u00fc","year":"2007","journal-title":"J Sichuan Univ (Medical Sciences)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-021-05377-9","article-title":"Age-related difference in extraocular muscles and its relation to clinical manifestations in an ethnically homogenous group of patients with Graves' orbitopathy","volume":"260","author":"Su","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000443828","article-title":"The 2016 European Thyroid Association\/European Group on Graves' Orbitopathy Guidelines for the management of Graves' orbitopathy","volume":"5","author":"Bartalena","year":"2016","journal-title":"Eur Thyroid J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000348246","article-title":"Differential involvement of orbital fat and extraocular muscles in Graves' ophthalmopathy","volume":"2","author":"Wiersinga","year":"2013","journal-title":"Eur Thyroid J"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)00712-5","article-title":"Direct orbital manometry in patients with thyroid-associated orbitopathy","volume":"106","author":"Riemann","year":"1999","journal-title":"Ophthalmology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0b013e31820365d5","article-title":"Densities of orbital fat and extraocular muscles in graves orbitopathy patients and controls","volume":"27","author":"Regensburg","year":"2011","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.5301\/ejo.5000018","article-title":"Graves' orbitopathy: extraocular muscle\/total orbit area ratio is positively related to the clinical activity score","volume":"22","author":"Le Moli","year":"2012","journal-title":"Eur J Ophthalmol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1767565\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:53:41Z","timestamp":1780462421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1767565\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":25,"alternative-id":["10.3389\/fendo.2026.1767565"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1767565","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"article-number":"1767565"}}